Vesugen (Lys-Glu-Asp) is a synthetic tripeptide from Vladimir Khavinson’s bioregulatory program, classified as a vascular bioregulator. Preclinical studies suggest effects on endothelial function and vascular tone. As with other Khavinson peptides, evidence comes primarily from Russian-language publications with limited Western replication.

📖 Read the full Vesugen research overview →

Evidence Tier: Tier 4 — Preclinical Only · Peptidings Verdict: Thin Ice